# Novartis takes rights to Abogen’s mRNA T cell engager for $575M upfront

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-02 19:29 UTC · Category: Business · Sources: 1 · Current Velocity: 0.25

## Key People, Organizations & Locations
Novartis, Abogen

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Endpoints News | Novartis takes rights to Abogen’s mRNA T cell engager for $575M upfront | 2026-10-02 08:55 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQX0tCUjRsQ0s0RkE4VXpYVDIyclU5NjY5Yk1jVFdmeURvRzV6azYzWml5WG9xZjFKLWxlYTZvajhXS0pTcWJ5WHpfc3hfOWhfV3ZtTWVLX0p3U09HcU1BcURTT21IZHlqMmF3dXZmSldWekxEUlhnLUsxWVJSVDhBTTFUZWEwUVhaSHduR3JGZnJ2QUhEWjdNcw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-02/novartis-takes-rights-to-abogen-s-mrna-t-cell-engager-for-575m-upfront*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*